Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium

American Journal of Health-System Pharmacy

Volumn 62, Issue 8, 2005, Pages 828-833

  Lee, Tzung Yi ^a   Chen, Chi Ming ^b   Lee, Chun Nin ^c   Chiang, Yi Chun ^b   Chen, Hsiang Yin ^b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acetylcysteine; Concentration; Fenoterol hydrobromide; Hydrogen ion concentration; Incompatibilities; Ipratroplum bromide; Mucolytic agents; Nebulizers; Osmolality; Parasympatholytic agents; Stability; Storage; Sympathomimetic agents

Indexed keywords

ACETYLCYSTEINE; FENOTEROL; IPRATROPIUM BROMIDE;

ARTICLE; DRUG INCOMPATIBILITY; DRUG MIXTURE; DRUG STABILITY; DRUG STORAGE; FREEZING; NEBULIZATION; NEBULIZER; OSMOLALITY; PH; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 17444375620     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.8.828     Document Type: Article

References (21)

1. Zainudin BM, Biddiscombe M, Tolfree SE et al. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurized metered dose inhaler, as a dry powder, and as a nebulized solution. Thorax. 1990; 45:469-73.
2. Newman SP. Aerosol deposition considerations in inhalation therapy. Chest. 1985; 88:152S-60S.
3. Gooch MD. Stability of albuterol and tobramycin when mixed for aerosol administration. Respir Care. 1991; 36:1387-90.
4. Joseph JC. Compatibility of nebulizer solution admixtures. Ann Pharmacother. 1997; 31:487-9.
5. Balmes JR, Fine JM, Christian D et al. Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis. 1988; 138(1):35-9.
6. Lowry RH, Wood AM, Higenbottam TW. Effects of pH and osmolarity on aerosol-induced cough in normal volunteers. Clin Sci. 1988; 74:373-6.
7. Chodosh S. Newer drugs in the treatment of chronic bronchitis. Med Clin North Am. 1967; 51:1169-79.
8. Hamlow EE, Peck GE. The stability of solutions of acetylcysteine to oxidation during nebulization. Anesthesiology. 1967; 28:934-5.
9. Reynold JE, ed. Martindale: the extra pharmacopoeia. London: Royal Pharmaceutical Press; 1996.
10. Kory RC, Hirsch SR, Giraldo J. Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis. A controlled study. Dis Chest. 1968; 54:504-9.
11. Hirsch SR, Viernes PF, Kory RC. Clinical and physiological evaluation of mucolytic agents nebulized with isoproterenol: 10 per cent N-acetylcysteine versus 10 per cent 2-mercaptoethane sulphonate. Thorax. 1970; 25:737-43.
12. Boulet LP, Turcotte H, Tennina S. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges. J Allergy Clin Immunol. 1989; 83:882-7.
13. Newton DW, Fung EY, Williams DA. Stability of five catecholamines and terbutaline sulfate in 5% dextrose injection in the absence and presence of aminophylline. Am J Hosp Pharm. 1981; 38:1314-9.
14. Jacoby DB, Fryer AD. Anticholinergic therapy for airway diseases. Life Sci. 2001; 68:2565-72.
15. Vadas EB. Stability of pharmaceutical products. In: Gennaro AR, Der Marderosian AR, eds. Remington: the science and practice of pharmacy. Philadelphia: Lippincott Williams & Wilkins; 2000: 986-94.
16. Gillham B, Young L. Biochemical studies of toxic agents. The isolation of premercapturic acids from the urine of animals dosed with chlorobenzene and bromobenzene. Biochem J. 1968; 109:143-7.
17. Newton DW. Physicochemical determinants of incompatibility and instability in injectable drug solutions and admixtures. Am J Hosp Pharm. 1978; 35:1213-22.
18. Wigent RJ. Chemical kinetics. In: Gennaro AR, Der Marderosian AR, eds. Remington: the science and practice of pharmacy. Philadelphia: Lippincott Williams & Wilkins; 2000:263-74.
19. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986; 2:1424-5.
20. Schoni MH, Kraemer R. Osmolality changes in nebulizer solutions. Eur Respir J. 1989; 2:887-92.
21. Desager KN, Van Bever HP, Stevens WJ. Osmolality and pH of anti-asthmatic drug solutions. Agents Actions. 1990; 31:225-8.